Fri, January 7, 2022

Drew Ranieri Upgraded (TMCI) to Buy and Held Target at $30 on, Jan 7th, 2022

Drew Ranieri of Morgan Stanley, Upgraded "Treace Medical Concepts, Inc." (TMCI) to Buy and Held Target at $30 on, Jan 7th, 2022.

Drew has made no other calls on TMCI in the last 4 months.



There is 1 other peer that has a rating on TMCI. Out of the 1 peers that are also analyzing TMCI, 0 agree with Drew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Drew


  • Danielle Antalffy of "SVB Leerink" Maintained at Buy with Decreased Target to $32 on, Friday, November 5th, 2021